Myc and Miz-1 have coordinate genomic functions including targeting Hox genes in human embryonic stem cells

Epigenetics and Chromatin

Volumn 4, Issue 1, 2011, Pages

  Varlakhanova, Natalia ^a,b   Cotterman, Rebecca ^a,b   Bradnam, Keith ^a   Korf, Ian ^a   Knoepfler, Paul S ^a,b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b SHRINERS HOSPITALS FOR CHILDREN NORTHERN CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DNA METHYLTRANSFERASE 3A; HISTONE DEACETYLASE; HISTONE H3; LYSINE; MYC PROTEIN; UNCLASSIFIED DRUG; ZINC FINGER PROTEIN; ZINC FINGER PROTEIN MIZ 1;

ARTICLE; CHROMATIN IMMUNOPRECIPITATION; DOWN REGULATION; EMBRYONIC STEM CELL; GENE EXPRESSION; GENE IDENTIFICATION; GENETIC VARIABILITY; HOX GENE; HUMAN; HUMAN CELL; LOSS OF FUNCTION MUTATION; ONCOGENE C MYB; ONCOGENE C MYC; PRIORITY JOURNAL; PROTEIN PROTEIN INTERACTION; TRANSCRIPTION INITIATION; UPREGULATION;

EID: 80355145604     PISSN: None     EISSN: 17568935     Source Type: Journal    
DOI: 10.1186/1756-8935-4-20     Document Type: Article

References (47)

1. An alternative pathway for gene regulation by Myc. Peukert K, Staller P, Schneider A, Carmichael G, Hanel F, Eilers M, EMBO J 1997 16 5672 5686 10.1093/emboj/16.18.5672 9312026 (Pubitemid 27399859)
2. Mechanisms of c-myc-mediated transcriptional repression of growth arrest genes. Gartel AL, Shchors K, Exp Cell Res 2003 283 17 21 10.1016/S0014-4827(02) 00020-4 12565816 (Pubitemid 36259892)
3. INK4b expression by Myc through association with Miz-1. Staller P, Peukert K, Kiermaier A, Seoane J, Lukas J, Karsunky H, Möröy T, Bartek J, Massague J, Hänel F, Eilers M, Nat Cell Biol 2001 3 392 399 10.1038/35070076 11283613 (Pubitemid 32288447)
4. A ribosomal protein L23-nucleophosmin circuit coordinates Miz1 function with cell growth. Wanzel M, Russ AC, Kleine-Kohlbrecher D, Colombo E, Pelicci P-G, Eilers M, Nat Cell Biol 2008 10 1051 1061 10.1038/ncb1764 19160485
5. Myc suppression of the p21(Cip1) Cdk inhibitor influences the outcome of the p53 response to DNA damage. Seoane J, Le HV, Massague J, Nature 2002 419 729 734 10.1038/nature01119 12384701 (Pubitemid 35177959)
6. Overexpression of Myc suppresses CCAAT transcription factor/nuclear factor 1-dependent promoters in vivo. Yang BS, Gilbert JD, Freytag SO, Mol Cell Biol 1993 13 3093 3102 8474463 (Pubitemid 23133980)
7. BCL6 interacts with the transcription factor Miz-1 to suppress the cyclin-dependent kinase inhibitor p21 and cell cycle arrest in germinal center B cells. Phan RT, Saito M, Basso K, Niu H, Dalla-Favera R, Nat Immunol 2005 6 1054 1060 10.1038/ni1245 16142238 (Pubitemid 41486191)
8. Zbtb4 represses transcription of P21CIP1 and controls the cellular response to p53 activation. Weber A, Marquardt J, Elzi D, Forster N, Starke S, Glaum A, Yamada D, Defossez PA, Delrow J, Eisenman RN, Christiansen H, Eilers M, EMBO J 2008 27 1563 1574 10.1038/emboj.2008.85 18451802 (Pubitemid 351794031)
9. A role of Miz-1 in Gfi-1-mediated transcriptional repression of CDKN1A. Liu Q, Basu S, Qiu Y, Tang F, Dong F, Oncogene 29 2843 2852
10. Myc represses transcription through recruitment of DNA methyltransferase corepressor. Brenner C, Deplus R, Didelot C, Loriot A, Viré E, De Smet C, Gutierrez A, Danovi D, Bernard D, Boon T, Pelicci PG, Amati B, Kouzarides T, de Launoit Y, Di Croce L, Fuks F, EMBO J 2005 24 336 346 10.1038/sj.emboj.7600509 15616584 (Pubitemid 40216138)
11. Myc-mediated transcriptional repression by recruitment of histone deacetylase. Kurland JF, Tansey WP, Cancer Res 2008 68 3624 3629 10.1158/0008-5472.CAN-07-6552 18483244
12. Amplification of endogenous myc-related DNA sequences in a human myeloid leukaemia cell line. Collins S, Groudine M, Nature 1982 298 679 681 10.1038/298679a0 6285209 (Pubitemid 12099731)
13. Reflecting on 25 years with MYC. Meyer N, Penn LZ, Nat Rev Cancer 2008 8 976 990 10.1038/nrc2231 19029958
14. Function of the c-Myc oncoprotein in chromatin remodeling and trasncription. Amati B, Frank SR, Donjerkovic D, Taubert S, Biochim Biophys Acta 2001 1471 135 M145 11250069
15. Oncogenic activity of the c-Myc protein requires dimerization with Max. Amati B, Brooks MW, Levy N, Littlewood TD, Evan GI, Land H, Cell 1993 72 233 245 10.1016/0092-8674(93)90663-B 8425220 (Pubitemid 23044938)
16. Analysis of genomic targets reveals complex functions of MYC. Patel JH, Loboda AP, Showe MK, Showe LC, McMahon SB, Nat Rev Cancer 2004 4 562 10.1038/nrc1393 15229481
17. The essential cofactor TRRAP recruits the histone acetyltransferase hGCN5 to c-Myc. McMahon SB, Wood MA, Cole MD, Mol Cell Biol 2000 20 556 562 10.1128/MCB.20.2.556-562.2000 10611234 (Pubitemid 30023097)
18. MYC recruits the TIP60 histone acetyltransferase complex to chromatin. Frank SR, Parisi T, Taubert S, Fernandez P, Fuchs M, Chan HM, Livingston DM, Amati B, EMBO Rep 2003 4 575 580 10.1038/sj.embor.embor861 12776177 (Pubitemid 36939948)
19. c-Myc regulates transcriptional pause release. Rahl PB, Lin CY, Seila AC, Flynn RA, McCuine S, Burge CB, Sharp PA, Young RA, Cell 2010 141 432 445 10.1016/j.cell.2010.03.030 20434984
20. Myc recruits P-TEFb to mediate the final step in the transcriptional activation of the cad promoter. Eberhardy SR, Farnham PJ, J Biol Chem 2002 277 40156 40162 10.1074/jbc.M207441200 12177005 (Pubitemid 35191008)
21. Myc regulates keratinocyte adhesion and differentiation via complex formation with Miz1. Gebhardt A, Frye M, Herold S, Benitah SA, Braun K, Samans B, Watt FM, Elsasser HP, Eilers M, J Cell Biol 2006 172 139 149 10.1083/jcb.200506057 16391002 (Pubitemid 43042636)
22. Myc increases self-renewal in neural progenitor cells through Miz-1. Kerosuo L, Piltti K, Fox H, Angers-Loustau A, Hayry V, Eilers M, Sariola H, Wartiovaara K, J Cell Sci 2008 121 3941 3950 10.1242/jcs.024802 19001505
23. Reciprocal regulation of adipogenesis by Myc and C/EBP alpha. Freytag SO, Geddes TJ, Science 1992 256 379 382 10.1126/science.256.5055.379 1566086
24. Mad4 is regulated by a transcriptional repressor complex that contains Miz-1 and c-Myc. Kime L, Wright SC, Biochem J 2003 370 291 298 10.1042/BJ20021679 12418961 (Pubitemid 36259442)
25. Role of the murine reprogramming factors in the induction of pluripotency. Sridharan R, Tchieu J, Mason MJ, Yachechko R, Kuoy E, Horvath S, Zhou Q, Plath K, Cell 2009 136 364 377 10.1016/j.cell.2009.01.001 19167336
26. Myc represses primitive endoderm differentiation in pluripotent stem cells. Smith KN, Singh AM, Dalton S, Cell Stem Cell 2010 7 343 354 10.1016/j.stem.2010.06.023 20804970
27. Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Takahashi K, Tanabe K, Ohnuki M, Narita M, Ichisaka T, Tomoda K, Yamanaka S, Cell 2007
28. myc maintains embryonic stem cell pluripotency and self-renewal. Varlakhanova NV, Cotterman RF, deVries WN, Morgan J, Donahue LR, Murray S, Knowles BB, Knoepfler PS, Differentiation 2010 80 9 19 10.1016/j.diff.2010.05. 001 20537458
29. LIF/STAT3 controls ES cell self-renewal and pluripotency by a Myc-dependent mechanism. Cartwright P, McLean C, Sheppard A, Rivett D, Jones K, Dalton S, Development 2005 132 885 896 10.1242/dev.01670 15673569 (Pubitemid 40484924)
30. Miz1 is required for early embryonic development during gastrulation. Adhikary S, Peukert K, Karsunky H, Beuger V, Lutz W, Elsasser HP, Moroy T, Eilers M, Mol Cell Biol 2003 23 7648 7657 10.1128/MCB.23.21.7648-7657.2003 14560010 (Pubitemid 37271463)
31. A SP1/MIZ1/MYCN repression complex recruits HDAC1 at the TRKA and p75NTR promoters and affects neuroblastoma malignancy by inhibiting the cell response to NGF. Iraci N, Diolaiti D, Papa A, Porro A, Valli E, Gherardi S, Herold S, Eilers M, Bernardoni R, Della Valle G, Perini G, Cancer Res 71 404 412
32. Whole-genome analysis of histone H3 lysine 4 and lysine 27 methylation in human embryonic stem cells. Pan G, Tian S, Nie J, Yang C, Ruotti V, Wei H, Jonsdottir GA, Stewart R, Thomson JA, Cell Stem Cell 2007 1 299 312 10.1016/j.stem.2007.08.003 18371364 (Pubitemid 47355329)
33. Unbiased location analysis of E2F1-binding sites suggests a widespread role for E2F1 in the human genome. Bieda M, Xu X, Singer MA, Green R, Farnham PJ, Genome Res 2006 16 595 605 10.1101/gr.4887606 16606705
34. MEME: discovering and analyzing DNA and protein sequence motifs. Bailey TL, Williams N, Misleh C, Li WW, Nucleic Acids Res 2006 34 369 373 10.1093/nar/gkl198 16845028 (Pubitemid 44529795)
35. CEAS: cis-regulatory element annotation system. Ji X, Li W, Song J, Wei L, Liu XS, Nucleic Acids Res 2006 34 551 554 10.1093/nar/gkl322 16845068 (Pubitemid 44529830)
36. Control of developmental regulators by Polycomb in human embryonic stem cells. Lee TI, Jenner RG, Boyer LA, Guenther MG, Levine SS, Kumar RM, Chevalier B, Johnstone SE, Cole MF, Isono K, Koseki H, Fuchikami T, Abe K, Murray HL, Zucker JP, Yuan B, Bell GW, Herbolsheimer E, Hannett NM, Sun K, Odom DT, Otte AP, Volkert TL, Bartel DP, Melton DA, Gifford DK, Jaenisch R, Young RA, Cell 2006 125 301 313 10.1016/j.cell.2006.02.043 16630818 (Pubitemid 44313811)
37. Epigenomic reorganization of the clustered Hox genes in embryonic stem cells induced by retinoic acid. Kashyap V, Gudas LJ, Brenet F, Funk P, Viale A, Scandura JM, J Biol Chem 2011 286 3250 3260 10.1074/jbc.M110.157545 21087926
38. Polycomb mediates Myc autorepression and its transcriptional control of many loci in Drosophila. Goodliffe JM, Wieschaus E, Cole MD, Genes Dev 2005 19 2941 2946 10.1101/gad.1352305 16357214 (Pubitemid 41798110)
39. A Myc network accounts for similarities between embryonic stem and cancer cell transcription programs. Kim J, Woo AJ, Chu J, Snow JW, Fujiwara Y, Kim CG, Cantor AB, Orkin SH, Cell 2010 143 313 324 10.1016/j.cell.2010.09.010 20946988
40. Gene regulation and epigenetic remodeling in murine embryonic stem cells by c-Myc. Lin CH, Lin C, Tanaka H, Fero ML, Eisenman RN, PLoS One 2009 4 7839 10.1371/journal.pone.0007839 19915707
41. Apoptotic signaling by c-MYC. Hoffman B, Liebermann DA, Oncogene 2008 27 6462 6472 10.1038/onc.2008.312 18955973
42. Hematopoietic stem cell function and survival depend on c-Myc and N-Myc activity. Laurenti E, Varnum-Finney B, Wilson A, Ferrero I, Blanco-Bose WE, Ehninger A, Knoepfler PS, Cheng PF, MacDonald HR, Eisenman RN, Bernstein ID, Trumpp A, Cell Stem Cell 2008 3 611 624 10.1016/j.stem.2008.09.005 19041778
43. Myc represses the p21(WAF1/CIP1) promoter and interacts with Sp1/Sp3. Gartel AL, Ye X, Goufman E, Shianov P, Hay N, Najmabadi F, Tyner AL, Proc Natl Acad Sci USA 2001 98 4510 4515 10.1073/pnas.081074898 11274368 (Pubitemid 32295007)
44. A bivalent chromatin structure marks key developmental genes in embryonic stem cells. Bernstein BE, Mikkelsen TS, Xie X, Kamal M, Huebert DJ, Cuff J, Fry B, Meissner A, Wernig M, Plath K, Jaenisch R, Wagschal A, Feil R, Schreiber SL, Lander ES, Cell 2006 125 315 326 10.1016/j.cell.2006.02.041 16630819
45. Myc-binding-site recognition in the human genome is determined by chromatin context. Guccione E, Martinato F, Finocchiaro G, Luzi L, Tizzoni L, Dall' Olio V, Zardo G, Nervi C, Bernard L, Amati B, Nat Cell Biol 2006 8 764 770 10.1038/ncb1434 16767079
46. Phase II trial of vinorelbine and trastuzumab in patients with HER2-positive metastatic breast cancer. A prospective, open label, non-controlled, multicenter phase II trial (to investigate efficacy and safety of this combination chemotherapy). Schilling G, Bruweleit M, Harbeck N, Thomssen C, Becker K, Hoffmann R, Villena C, Schutte M, Hossfeld DK, Bokemeyer C, de Wit M, Invest New Drugs 2009 27 166 172 10.1007/s10637-008-9166-8 18696011
47. N-Myc regulates a widespread euchromatic program in the human genome partially independent of its role as a classical transcription factor. Cotterman R, Jin VX, Krig SR, Lemen JM, Wey A, Farnham PJ, Knoepfler PS, Cancer Res 2008 68 9654 9662 10.1158/0008-5472.CAN-08-1961 19047142